Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 30, 2024

Study Completion Date

April 7, 2024

Conditions
Laparoscopic Hepatectomy
Interventions
DRUG

Dobutamine hydrochloride, Injectable

In the dobutamine group, 3\~6μg/kg/min dobutamine will be injected intravenously after anesthesia induction until hemostasis is completed. The dose of dobutamine will be increased if the operating field grade exceeds Grade II. Monitoring LVEDV and SV with TEE to ensure preload: after admission, the patient will be given 3-4 mL /kg/h equilibrium fluid as background infusion. LVEDV and SV will be monitored using TEE every 30 minutes after anesthesia induction. If LVEDV\<75mL or SV\<45mL, 200mL colloidal fluid will be given within 5min.

DRUG

0.9% normal saline

In the control group, 3mL/h normal saline will be injected intravenously after anesthesia induction until hemostasis is completed. According to the currently commonly used principle of LCVP, the fluid will be limited to 3-4 ml /kg/h after anesthesia induction. If the operating field grade exceeds Grade II, nitroglycerin will be injected intravenously for remedial purposes at a rate of 0.3-0.8μg/kg/min.

Trial Locations (1)

610041

West China Hospital, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER

NCT06210217 - Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum | Biotech Hunter | Biotech Hunter